Diosuxentan
Diosuxentan is an investigational new drug that is being developed by Biocity Biopharmaceutics for the treatment of diabetic nephropathy.
≈ 1 min read
Names in other languages
No names in other languages are held for this entry yet.
Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.
Diosuxentan is an investigational new drug that is being developed by Biocity Biopharmaceutics for the treatment of diabetic nephropathy. It is an endothelin A receptor antagonist.
Text derived from https://en.wikipedia.org/w/index.php?oldid=1365630375 under CC BY-SA 4.0; modifications have been made.